Earthgenes Pharmaceuticals LLC Lexington, MA - 02421

Earthgenes Pharmaceuticals LLC is categorized under Drugs, Proprietaries, and Sundries in Lexington, MA and active since 2004.

Earthgenes Pharmaceuticals LLC was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Marcia S Osburne at the company’s single location by writing to 107 Cedar St, Lexington, Massachusetts MA 02421 or by phoning (781) 862-3801. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Earthgenes Pharmaceuticals LLC
Contact Person: Marcia S Osburne
Address: 107 Cedar St, Lexington, Massachusetts 02421
Phone Number: (781) 862-3801
Annual Revenue (USD): $100.000 to $499.999
Founded: 2004
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Drugs, Proprietaries, and Sundries
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Earthgenes Pharmaceuticals LLC was started in 2004 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Marcia S Osburne for inquiries that concern Earthgenes Pharmaceuticals LLC by calling the company number (781) 862-3801, as your correspondence is most welcome. Additionally, the physical location of the single location of Earthgenes Pharmaceuticals LLC can be found at the coordinates 42.452419,-71.246764 as well as the street address 107 Cedar St in Lexington, Massachusetts 02421.

For its online presence, you may visit Earthgenes Pharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.